Sr.No. PAN Legal Name Trade Name Mobile No Email ID GSTIN 1
Total Page：16
File Type：pdf, Size：1020Kb
Load more
Recommended publications
-
Replacements in Indices
Date: February 21, 2018 PRESS RELEASE Replacements in Indices The Index Maintenance Sub-Committee (IMSC) has decided to make the following replacement of stocks in various indices as part of its periodic review. These changes shall become effective from April 02, 2018 (close of March 28, 2018). 1) NIFTY 50 The following companies are being excluded: Sr. No. Company Name Symbol 1 Ambuja Cements Ltd. AMBUJACEM 2 Aurobindo Pharma Ltd. AUROPHARMA 3 Bosch Ltd. BOSCHLTD The following companies are being included: Sr. No. Company Name Symbol 1 Bajaj Finserv Ltd. BAJAJFINSV 2 Grasim Industries Ltd. GRASIM 3 Titan Company Ltd. TITAN The above replacements will also be applicable to NIFTY50 Equal Weight Index. 2) NIFTY Next 50 The following companies are being excluded: Sr. No. Company Name Symbol 1 Bajaj Finserv Ltd. BAJAJFINSV 2 GlaxoSmithkline Consumer Healthcare Ltd. GSKCONS 3 Glaxosmithkline Pharmaceuticals Ltd. GLAXO 4 Glenmark Pharmaceuticals Ltd. GLENMARK 5 Tata Power Co. Ltd. TATAPOWER 6 Titan Company Ltd. TITAN 7 Torrent Pharmaceuticals Ltd. TORNTPHARM The following companies are being included: Sr. No. Company Name Symbol 1 Aditya Birla Capital Ltd. ABCAPITAL Sr. No. Company Name Symbol 2 Ambuja Cements Ltd. AMBUJACEM 3 Aurobindo Pharma Ltd. AUROPHARMA 4 Bosch Ltd. BOSCHLTD 5 General Insurance Corporation of India GICRE 6 L&T Finance Holdings Ltd. L&TFH 7 SBI Life Insurance Company Ltd. SBILIFE 3) NIFTY 500 The following companies are being excluded: Sr. No. Company Name Symbol 1 Adani Enterprises Ltd. ADANIENT 2 Ahluwalia Contracts (India) Ltd. AHLUCONT 3 Apar Industries Ltd. APARINDS 4 AstraZenca Pharma India Ltd. ASTRAZEN 5 Corporation Bank CORPBANK 6 Dalmia Bharat Ltd. -
50 KW Offer Solar Copy 2
21st Century Enviro Engineers Pvt.Ltd. Plot No. 120(10 Marla), COMPANY Industrial Area Phase II Chandigarh - 160002, India PROFILE www.21stcenturyenviro.com INTRODUCTION 21st CENTURY ENVIRO ENGINEERS PVT. LTD. is a Company dealing in the field of Environmental Engineering related activities. We are Registered Environmental Consultants of Pollution Control Board to Supply ETP’s, STP’s, APCD’s, Incinerators, Water Treatment Plants, Reverse Osmosis, Evaporators, Solid Waste Management and Rain Water Harvesting and to carry out EIA Studies . The Directors of the company are young Technocrats having versatile experience in this field. We have a back up of highly qualified and experienced technical team having versatile experience in Designing, Erection, Commissioning and Operation of different types of Effluent Treatment Plants. Our Managing Director himself is a Chemical Engineer with almost 25 Years Experience in this line and Technical Director is PhD. in Environmental Science with almost 30 Years working experience on various types of effluent treatment Technologies. Our team comprises of almost 150 people from different backgrounds e.g. Chemical, Environmental, Mechanical, Instrumentation, Civil, Accounts, Purchase, Marketing etc. We have our Marketing/ Design Office in Chandigarh and regional offices in Dhaka, Mumbai, New Delhi, Sikkim etc. and have our own testing Laboratory for Effluent/Water Testing and to study treatability of effluent on pilot scale. We have our own full-fledged manufacturing unit of Pollution Control Equipments in Village Kunjhal Baddi (HP). We also undertake annual operation and maintenance contracts and liasining services for the systems supplied by us. We are also Registered with CREST (Chandigarh Renewable Energy & Technology Promotion Society) and SECI (Solar Energy Corporation of India) for supplying Online/Offline Solar systems in Chandigarh, Himachal Pradesh, Uttarakhand, J&K, Punjab, Haryana, Delhi, Bihar etc. -
Index Stock Update >> Marico Stock Update >> Gabriel India Stock Update >> PTC India Stock
Visit us at www.sharekhan.com November 04, 2015 Index Stock Update >> Marico Stock Update >> Gabriel India Stock Update >> PTC India Stock Update >> Ipca Laboratories Stock Update >> Skipper Viewpoint >> Lloyd Electric & Engineering For Private Circulation only REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai – 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/ INF231073330 ; CD-INE231073330 ; MSEI - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS- INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX- 00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at [email protected] ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do’s & Don’ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. investor’s eye stock update Marico Reco: Buy Stock Update Enhanced focus to improve volume growth; maintain Buy CMP: Rs399 Company details Key points Price target: Rs460 Mixed operating performance: During Q2FY2016, Marico’s revenue grew by 4% to Rs1,485.4 crore, entirely driven by a 4% volume growth (domestic business’ volume Market cap: Rs25,735 cr growth stood at 5.5%). The gross profit margin (GPM) improved by almost 500BPS to 52 week high/low: Rs466/299 49.3% on the back of ~30% decline in the copra prices and 33% decline in the prices of liquid paraffin. -
(Public Section) Padma Awards Directory (1954-2009) Year-Wise List Sl
MINISTRY OF HOME AFFAIRS (Public Section) Padma Awards Directory (1954-2009) Year-Wise List Sl. Prefix First Name Last Name Award State Field Remarks 1954 1 Dr. Sarvapalli Radhakrishnan BR TN Public Affairs Expired 2 Shri Chakravarti Rajagopalachari BR TN Public Affairs Expired 3 Dr. Chandrasekhara Raman BR TN Science & Eng. Expired Venkata 4 Shri Nand Lal Bose PV WB Art Expired 5 Dr. Satyendra Nath Bose PV WB Litt. & Edu. 6 Dr. Zakir Hussain PV AP Public Affairs Expired 7 Shri B.G. Kher PV MAH Public Affairs Expired 8 Shri V.K. Krishna Menon PV KER Public Affairs Expired 9 Shri Jigme Dorji Wangchuk PV BHU Public Affairs 10 Dr. Homi Jehangir Bhabha PB MAH Science & Eng. Expired 11 Dr. Shanti Swarup Bhatnagar PB UP Science & Eng. Expired 12 Shri Mahadeva Iyer Ganapati PB OR Civil Service 13 Dr. J.C. Ghosh PB WB Science & Eng. Expired 14 Shri Maithilisharan Gupta PB UP Litt. & Edu. Expired 15 Shri Radha Krishan Gupta PB DEL Civil Service Expired 16 Shri R.R. Handa PB PUN Civil Service Expired 17 Shri Amar Nath Jha PB UP Litt. & Edu. Expired 18 Shri Malihabadi Josh PB DEL Litt. & Edu. 19 Dr. Ajudhia Nath Khosla PB DEL Science & Eng. Expired 20 Shri K.S. Krishnan PB TN Science & Eng. Expired 21 Shri Moulana Hussain Madni PB PUN Litt. & Edu. Ahmed 22 Shri V.L. Mehta PB GUJ Public Affairs Expired 23 Shri Vallathol Narayana Menon PB KER Litt. & Edu. Expired Wednesday, July 22, 2009 Page 1 of 133 Sl. Prefix First Name Last Name Award State Field Remarks 24 Dr. -
Inner 25 India Pharma & Healthcare Fund
Modera erate tely Mod High to e H w at ig o er h L d o M V e r y w H Tata India Pharma & Healthcare Fund o i L g (An open ended equity scheme investing in Pharma and Healthcare Services Sector) h Riskometer Investors understand that their principal As on 30th June 2021 PORTFOLIO will be at Very High Risk INVESTMENT STYLE Company name No. of Market Value % of Company name No. of Market Value % of Primarily focuses on investment in at least 80% of its net Shares Rs. Lakhs Assets Shares Rs. Lakhs Assets assets in equity/equity related instruments of the companies in the Pharma & Healthcare sectors in India. Equity & Equity Related Total 55184.24 97.88 Glenmark Pharmaceuticals Ltd. 167000 1089.76 1.93 INVESTMENT OBJECTIVE Healthcare Services Sanofi India Ltd. 13000 997.39 1.77 The investment objective of the scheme is to seek long Apollo Hospitals Enterprise Ltd. 70500 2551.99 4.53 Gland Pharma Ltd. 19662 673.29 1.19 term capital appreciation by investing atleast 80% of its Fortis Healthcare Ltd. 795000 1935.03 3.43 Laurus Labs Ltd. 90000 619.79 1.10 net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in Syngene International Ltd. 265000 1545.75 2.74 India.However, there is no assurance or guarantee that the investment objective of the Scheme will be Narayana Hrudayalaya Ltd. 301420 1483.74 2.63 Other Equities^ 1186.14 2.10 achieved.The Scheme does not assure or guarantee any Metropolis Healthcare Ltd. -
Ipca Laboratories (IPCLAB)
Ipca Laboratories (IPCLAB) CMP: | 2040 Target: | 2290 (12%) Target Period: 12 months HOLD May 31, 2021 Upbeat guidance, execution remains key Q4 revenues remained subdued growing just 3.8% YoY to | 1115 crore. Strong YoY growth of 19.7% in export formulations to | 338 crore was partly Particulars offset by API sales decline of 5.5% YoY to | 260 crore. Domestic Particular Amount formulations remained flat at | 434 crore vs. | 431 crore in Q4FY20. EBITDA Market Capitalisation | 25873 crore margins improved 484 bps YoY to 20.5% due to better gross margins and Debt (FY21) | 267 crore lower other expenditure. EBITDA grew 35.8% YoY to | 229 crore. PAT grew Cash (FY21) | 365 crore 87.5% YoY to | 161 crore (I-direct estimate: | 204 crore). Delta vis-à-vis EV | 25775 crore EBITDA was due to higher other income, lower depreciation and tax rate. 52 week H/L (|) 2456/1467 Equity capital | 25.4 crore Update Result Export formulations main catalyst for growth Face value | 2 Price performance Growth in export formulations (29% of FY21 revenues) was on the back of growth in both international generics and international branded 2500 14000 formulations. The international anti-malarial institutional business has also 12000 2000 contributed substantially to overall exports growth. US traction will take 10000 longer than earlier estimated due to USFDA import alerts for the Ratlam 1500 8000 facility that is the only API source for Silvassa and Pithampur formulations 1000 6000 plants along with Silvassa and Pithampur (Indore) plants that are specifically 4000 500 earmarked for the US business, besides third party sales. -
Take a Sad Song and Make It Better: an Alternative Reading of Anglo-Indian Stereotypes in Shyamaprasad’S Hey Jude (2018)
TAKE A SAD SONG AND MAKE IT BETTER: AN ALTERNATIVE READING OF ANGLO-INDIAN STEREOTYPES IN SHYAMAPRASAD’S HEY JUDE (2018) Glenn D’Cruz ABSTRACT This Paper provides an alternative approach to understanding the function of Anglo- Indian culture in Shyamaprasad’s Malayalam language film Hey Jude (2018). Drawing on his theorization of Anglo-Indian Stereotypes in his book Midnight’s Orphans: Anglo-Indians in Post/Colonial Literature (Peter Lang, 2006), the author contests the reading of the film offered by Rajesh James and Priya Alphonsa Mathew in their recent article, ‘Between Two Worlds: Anglo-Indian Stereotypes and Malayalam Cinema.’ Rather than hastily dismissing representations of Anglo-Indians in Hey Jude as stereotypical and offensive, this critique of James and Mathew’s argument underscores the importance of situating the film in a broader context and paying more detailed attention to the cultural work performed by its themes and tropes. INTRODUCTION FADE IN: INT. Number 13 Charles Street, East London. Early Evening. 1968. A deep red lamp illuminates a framed picture of the Sacred Heart of Jesus. Thick trails of cigarette smoke waft into the frame from below, shrouding the ceremonial lamp in a fog that diminishes its glow. The deep, dulcet tones of Jim Reeves singing ‘Yonder Comes a Sucker’ can be heard over the sound of chatter, laughter, and clinking glasses. IJAIS Vol. 18, No. 2. 2018 pp. 32-47 www.international-journal-of-anglo-indian-studies.org Take a Sad Song and Make it Better 33 DISSOLVE TO: INT: Number 13 Charles Street. Front Room. The Room is populated by a group of young men and women in their late twenties and early thirties. -
District Ahmednagar
LIST OF PERMANENT SSI REGISTERED UNITS - DISTRICT AHMEDNAGAR. REGN REGN_ NAME OF THE UNIT ADR1 ADR2 MAJ_ACT_NAME1 PROD_NAME1 DIR_UNIT_NA DIR_UNI DIR_ADR DIR_ NO. YEAR ME1 T_NAME 1 ADR 2 2 M/S. CTS SA LEELAVATI NO.26/2 VE SHARAT , DI, M/S. POLICE AHMEDNA STATIO GAR PIPES. N, M/S.SATISH 29,CHA ,AH INDUSTRIE HURAN ME S, A DN M/S.SHRIR CS,NO. O.3 AM 1290,A- SH BOREWELL 1H.NO. RIR M/S.KARTIK S.NO.2 AD COPUTERS 74,/A10- E . 15,PLO MA M/S.AGRA ANANT EDI, WAL NIWAS, A`N INDUSTRIE MAHAV AG SHREE 5834 MARBLE TILAK ROAD MAHARASH NISAR TRA I.KURE FURNITUR SHI,H.N M/S. H.NO.1 TAL TRIMURTI 90, .SH ICE CAND MALWA RIG FAST-FAB 1101 DIS ENGINEERI KALKAI T NG WORKS SHRIG AH M/S.YOGAN 204,NI N,A DHARA WARA `NA FOOD TALKIE GA M/S. S.NO.1 GO SAIKRIPA 01/1+2, ND VEET RANJA AW NEW MOULA AH SUCCESS NA ME ENGINEERI AZAD DN FIBREX 107 ME INDUSTRIE BDATR DN S. ANGE AG AJID CHAHU AH HANSRAJ RANA ME KABNAWAT BK DN MANOHAR 5159 AH ENGINEERI MAHAT ME NG WORKS MA DN 3841 1997 BASE ACADEMY OF GALA NO. 65, MARKET M/S.BASE DUCAT GALA G COMPUTER YARD, SHOPING, ACADEMY ION. NO- CE AHMEDNAGAR OF 65,MAR NT KAMDHENU G.NO.1 POULTRY 0,BOND FARM RE,TAL- M/S. CST AH S.P.MUTHA NO.368 ME & 0, DN M/S. C-2/9, CH SHREYAS ANAND OW PRODUCTS NAGAR K, Page 1 DIC AHMEDNAGAR FRAME LIST M/S.VIMAL P.NO.1 PTA PLASTIC. -
8Th Pune International Film Festival ( 7Th - 14Th January 2010 ) SR
8th Pune International Film Festival ( 7th - 14th January 2010 ) SR. NO. TITLE ORIGINAL TITLE RUNTIME YEAR DIRECTOR COUNTRY OPENING FILM 1 About Elly DARBAREYE ELLY 119 2009 ASGHAR FARHADI IRAN WORLD COMPETITION 1 WHITE LIGHTENIN' - WC WHITE LIGHTNIN' 90 2009 Dominic Murphy UK 2 THE LITTLEONE LA PIVELLINA 100 2009 Tizza Covi, Rainer Frimmel Italy-Austria Alejandro Fernández Almendras - 3 HUACHO - WC HUACHO 89 Chile-France GERMANY CONFIRMED 4 APPLAUSE APPLAUS 86 2009 Martin Zandvliet Denmark CEA MAI FERICITA FATA DIN 5 The happiest girl in the world 100 2009 Radu Jude Romania LUME KIELLETY HEDELMÄ , Dome 6 FORBIDDEN FRUIT -WC 98 2009 Dome Karukoski FINLAND sweden karukoski WHO IS AFRAID OF THE WOLF 7 KDOPAK BY SE VLKA BÁL 90 2008 Maria Procházková czech republic -WC 8 SCRATCH -WC RYSA 89 2009 Michal Rosa poland 9 THE OTHER BANK -WC GAGMA NAPIRI 90 2009 George Ovashvili poland 10 I SAW THE SUN -WC GÜNESI GÖRDÜM 120 2009 Mahsun Kirmizigül. TURKEY THE MAN BEYOND THE BRIDGE- 11 PALTADACHO MUNIS 96 2009 Laxmikant Shetgaonkar INDIA WC 12 FRONTIER BLUES- WC FRONTIER BLUES 95 2009 Babak Jalali Iran-UK-Italy 13 77 DORONSHIP-WC 77 DORONSHIP 90 2009 Pablo Agüero france 14 OPERATION DANUBE-WC OPERACE DUNAJ 104 2009 Jacek Glomb poland 15 THE STRANGER IN ME -WC DAS FREMDE IN MIR 99 2009 Emily Atef GERMANY Marathi competition 1 RITA 145 2009 RENUKA SHAHANE India 2 PAANGIRA 135 2009 RAJEEV PATIL India GOSHTA CHOTI DONGRA 3 GOSHTA CHOTI DONGRA EVDHI 120 2009 NAGESH BHOSALE India EVDHI 4 VIHIR 120 2009 UMESH KULKARNI India 5 A CUP OF TEA EK CUP CHYA 120 -
Pharma Sector Report -Sept’20
Mutual Fund: Pharma Sector Report -Sept’20 Private & confidential. Only for limited circulation. Contact us: [email protected] Executive Summary: Since the outbreak of the Coronavirus crisis, the pharma sector stepped into the spotlight. Long overdue investments have been flowing towards the sector and even pharma funds in the mutual fund industry have begun to outperform. Nevertheless, there is still a clear need for government spending in this sector. Compared to the US, which has the highest per capita spending on healthcare at $5000, India spends merely ~ $50 per capita. The current situation presents the Indian government with a perfect opportunity to increase its expenditure in this sector, to facilitate its growth and fast-track its progress. Few points about the Pharma Funds: The market capitalization of the entire pharma & healthcare industry is ~ Rs. 10 lac crs, whereas the total size of pharma funds in the mutual fund is ~Rs. 10k crs, translating to ~ 1% of the entire sector in value terms. (This excludes the pharma holdings in other categories). There are 43 pharma & healthcare companies that form part of the Top 500 companies. Out of these, pharma funds have an exposure to 36 companies. There are 11 companies in the Top 100; 11 in the Midcap space (101-250) and 14 Smallcaps (251-500). The 7 companies that do not form part of the pharma funds’ portfolios are Caplin Point Lab, Glenmark Pharma, Granules India, Piramal Enterprises, Poly Medicure, Suven Pharma and Wockhardt Ltd. Cipla Ltd., Divis Laboratories Ltd. and Dr. Reddy’s Laboratories Ltd. are the only stocks that form part of every pharma fund. -
List of 3Rd Party Manufacturer of Pre-Qualified/Registered Firms with PPT Hospital
List of 3rd party Manufacturer of Pre-qualified/Registered Firms with PPT Hospital SL. Name of the Parent Firm Name of the 3rd party manufacturer NO A B C 1 M/s AKUMENTIS HEALTHCARE LTD. (i) M/S Unimark Healthcare Ltd (ii) M/S Applied Communication & Controls (iii) Maxcure Nutravedics Ltd (iv) Akums Drugs & Pharmaceuticals Ltd 2 M/s ALCON LABORATORIES(INDIA)PVT.LTD (i) M/S Wintac Limited 3 M/s ABBOTT HEALTHCARE PVT. LTD. (i) Akums Drugs & Pharmaceuticals Ltd (ii) Medibios Laboratories Pvt. Ltd. (iii) Tristar Formulations Pvt. Ltd. (iv) Hetero Labs Ltd (v) M/S Aqua Vitoe Laboratories 4 M/s ABBOTT INDIA LIMITED. (i) Acme Formulation Pvt Ltd (ii) Revenbhel Healthcare Pvt. Ltd. 5 M/s CENTAUR PHARMACEUTICALS PVT. LTD. (i) M/S Pure & Cure Healthcare Pvt. Ltd. (ii) M/S The Madras Pharmaceuticals (iii) M/S Akums Drugs & Pharmaceuticals Limited 6 M/S CIPLA LIMITED (i) Akums Drugs & Pharmaceuticals Ltd (ii) BDR Pharmaceuticals International Pvt. Ltd. (iii) M/S Medispray Laboratories Pvt. Ltd. (iv) M/S Golden Cross Pharma Pvt. Ltd. (v) M/S Tirupati Medicare Limited (vi) M/S Mepromax Lifesciences PVT Ltd. (vii) M/S Virchow Biotech Private Limited (viii) Hetero Labs Ltd (ix) Pegasus Farmaco Iindia Pvt. Ltd. (x) Meditab Specialities Pvt. Ltd. 7 M/s DR. REDDYS LABORATORIES LTD (i) Bdr Pharmaceuticals Ltd (ii) Naprod Lifesciences Pvt. Ltd (iii) Hetero Labs Ltd (iv) Natco Pharma Ltd (v) Amgen Manufacturing Limited 8 M/s FOURRTS (INDIA) LABORATORIES PVT. (i) M/S Swiss Garnier Biotech (ii) M/S Sun Glow Pharmaceuticals Private Limited 9 M/s GLOBUS REMEDIES (i) Park Pharmaceuticals (ii) Baxil Pharma Pvt. -
S.No Reg. No Company Name 1 2 AHMEDABAD MANUFACTURING and CALICO PRINTING CO
LIST OF DEFAULTING COMPANIES IN GUJRAT S.No Reg. No Company_Name 1 2 AHMEDABAD MANUFACTURING AND CALICO PRINTING CO. LTD. 2 3 GUJARAT GINNING & MFG CO.LIMITED. 3 7 THE ARYODAYA SPG & WVG.CO.LIMITED. 4 8 40817HCHOWK & AHMEDABAD MFG CO.LIMITED. 5 9 RAJNAGAR SPG & WVG MFG.CO.LIMITED. 6 10 HMEDABAD COTTON MFG. CO.LIMITED. 7 12 12DISPLAY STATUSSTEEL INDUSTRIES PVT. LTD. 8 18 ISHWER COTTON G.N.& PRES.CO.LIMITED. 9 22 THE AHMEDABAD NEW COTTON MILLS CO.LIMITED. 10 25 BHARAT KHAND TEXTILE MANUFACTURING CO LTD 11 27 HIMABHAI MANUFACTURING CO LTD 12 29 JEHANGIR VAKIL MILLS CO PVT LTD 13 30 GUJARAT OIL MILL & MFG CO LTD 14 31 RUSTOMJI MANGALDAS & COMPANY LTD 15 34 FINE KNITTING CO LTD 16 40 AHMEDABAD LAXMI COTTON MILLS CO.LIMITED. 17 42 AHMEDABAD KAISER-I-HIND MILLS CO LTD 18 45 AHMEDABAD NEW TEXTILE MILS CO LTD 19 47 SHRI VIVEKANAND MILLS LTD 20 49 MARSDEN SPINNING & MANUFACTURING CO LTD 21 50 ASHOKA MILLS LTD. 22 54 AHMEDABAD CYCLE & MOTORS TRADING CO PVT LTD 23 68 SHRI AMRUTA MILLS LTD 24 78 VIJAY MILLS CO LTD 25 79 SHRI ARBUDA MILLS LTD. 26 81 DHARWAR ELECTRICAL INDUSTRIES LTD 27 85 ANANTA MILLS LTD 28 87 BHIKABHAI JIVABHAI & CO PVT LTD 29 89 J R VAKHARIA & SONS PVT LTD 30 99 BIHARI MILLS LIMITED 31 101 ROHIT MILLS LTD 32 106 AHMEDABAD FIBRE-SALES & SUPPLIES LTD 33 107 GUJARAT PAPER MILLS LTD 34 109 IDEAL MOTORS LTD 35 110 MODEL THEATRES PVT LTD 36 115 HIMATLAL MOTILAL & CO LTD.(IN LIQ.) 37 116 RAMANLAL KANAIYALAL & CO LTD.(LIQ).